Research and Development in Advanced Technologies and Commercialization through Collaboration with Toshiba
First written in FY2016. 26 of 30 entries say "Restated". Latest entry: FY2026.
115 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「The Company targeted total research and development-related investment of ¥20 billion during the period covered by the medium-term management plan and invested ¥23.1 billion cumulatively over the period through these initiatives. In addition to these initiatives, construction of a new research and development building at the Yokohama facility and expansion of the cleanroom at the Sagamino facility, undertaken to promote research and development in the semiconductor manufacturing equipment field, where demand is expected to continue increasing, were completed during the period covered by the medium-term management plan. The new research and development building has been operational since August 2025, and the expanded cleanroom has been operational since April 2024.」
Research and development-related investment totaled ¥23.1 billion, compared with the medium-term plan target of ¥20 billion. The new research and development building in Yokohama and the expanded cleanroom in Sagamino were also completed and became operational. - 2026-05-13AdvancedEarnings presentation
「We will use the research and development equipment and evaluation machines in which we invested during Phase 1 to further strengthen and accelerate development.」
The company plans to continue using its research and development equipment and evaluation machines and to invest approximately ¥13.5 billion in research and development during Phase 2. - FY2026-H1RestatedAnnual report
「The amount of research and development activities for the Group as a whole during the interim consolidated accounting period was ¥2,033 million. There were no material changes in the status of the Group's research and development activities during the interim consolidated accounting period.」
The company continued its research and development activities, bringing research and development expenses for the interim consolidated accounting period to ¥2,033 million. It states that there were no material changes in the status of these activities. - FY2025-H1RestatedAnnual report
「The amount of research and development activities for the Group as a whole during the interim consolidated accounting period was ¥1,869 million. There were no material changes in the status of the Group's research and development activities during the interim consolidated accounting period.」
The company states that there were no material changes in its research and development activities and reports research and development expenses of ¥1,869 million for the interim consolidated accounting period. - FY2024-Q3RestatedAnnual report
「The amount of research and development activities for the Group as a whole during the nine-month consolidated cumulative period was ¥2,465 million. There were no material changes in the status of the Group's research and development activities during the nine-month consolidated cumulative period.」
The company continued its research and development activities, bringing cumulative research and development expenses to ¥2,465 million. It states that there were no material changes in the status of its research and development activities. - FY2024-Q2RestatedAnnual report
「The amount of research and development activities for the Group as a whole during the six-month consolidated cumulative period was ¥1,681 million. There were no material changes in the status of the Group's research and development activities during the six-month consolidated cumulative period.」
The company continued its research and development activities, bringing cumulative research and development expenses to ¥1,681 million. There were no material changes in the status of these activities. - FY2024-Q1RestatedAnnual report
「The amount of research and development activities for the Group as a whole during the three-month consolidated cumulative period was ¥762 million. There were no material changes in the status of the Group's research and development activities during the three-month consolidated cumulative period.」
The company recorded research and development expenses of ¥762 million and states that there were no material changes in the status of its research and development activities. - FY2023-Q3RestatedAnnual report
「The amount of research and development activities for the Group as a whole during the nine-month consolidated cumulative period was ¥2,230 million. There were no material changes in the status of the Group's research and development activities during the nine-month consolidated cumulative period.」
The company continued its research and development activities, bringing cumulative research and development expenses to ¥2,230 million. It states that there were no material changes in the status of these activities. - FY2023-Q2RestatedAnnual report
「The amount of research and development activities for the Group as a whole during the six-month consolidated cumulative period was ¥1,404 million. There were no material changes in the status of the Group's research and development activities during the six-month consolidated cumulative period.」
The company continued its research and development activities, bringing cumulative research and development expenses to ¥1,404 million. There were no material changes in the status of these activities. - FY2023-Q1RestatedAnnual report
「The amount of research and development activities for the Group as a whole during the three-month consolidated cumulative period was ¥606 million. There were no material changes in the status of the Group's research and development activities during the three-month consolidated cumulative period.」
The company states that there were no material changes in its research and development activities and reports research and development expenses of ¥606 million for the three-month cumulative period. - FY2022-Q3RestatedAnnual report
「The amount of research and development activities for the Group as a whole during the nine-month consolidated cumulative period was ¥1,906 million. There were no material changes in the status of the Group's research and development activities during the nine-month consolidated cumulative period.」
The company continued its research and development activities, bringing cumulative research and development expenses to ¥1,906 million. It states that there were no material changes in the status of these activities. - FY2022-Q2RestatedAnnual report
「The amount of research and development activities for the Group as a whole during the six-month consolidated cumulative period was ¥1,317 million. There were no material changes in the status of the Group's research and development activities during the six-month consolidated cumulative period.」
The company continued its research and development activities and reports research and development expenses of ¥1,317 million for the six-month cumulative period. There were no material changes in the status of these activities. - FY2022-Q1RestatedAnnual report
「The amount of research and development activities for the Group as a whole during the three-month consolidated cumulative period was ¥602 million. There were no material changes in the status of the Group's research and development activities during the three-month consolidated cumulative period.」
The company states that there were no material changes in its research and development activities and reports research and development expenses of ¥602 million for the three-month cumulative period. - FY2021-Q3RestatedAnnual report
「The amount of research and development activities for the Group as a whole during the nine-month consolidated cumulative period was ¥1,819 million. There were no material changes in the status of the Group's research and development activities during the nine-month consolidated cumulative period.」
The company states that there were no material changes in its research and development activities and reports research and development expenses of ¥1,819 million for the nine-month cumulative period. - FY2021-Q2RestatedAnnual report
「The Group's R&D activities amounted to ¥1,280 million during the first 2 quarters. There were no material changes in the status of the Group's R&D activities during the first 2 quarters.」
The Company stated that there were no material changes in its R&D activities and reported R&D expenses of ¥1,280 million for the first 2 quarters. - FY2021-Q1RestatedAnnual report
「The Group's R&D activities amounted to ¥589 million during the first quarter. There were no material changes in the status of the Group's R&D activities during the first quarter.」
The Company stated that there were no material changes in its R&D activities and reported R&D expenses of ¥589 million for the first quarter. - FY2020-Q3RestatedAnnual report
「The Group's R&D activities amounted to ¥2,009 million during the first 3 quarters. There were no material changes in the status of the Group's R&D activities during the first 3 quarters.」
The Company stated that there were no material changes in its R&D activities and reported R&D expenses of ¥2,009 million for the first 3 quarters. - FY2020-Q2RestatedAnnual report
「The Group's R&D activities amounted to ¥1,368 million during the first 2 quarters. There were no material changes in the status of the Group's R&D activities during the first 2 quarters.」
The Company stated that there were no material changes in its R&D activities and reported R&D expenses of ¥1,368 million for the first 2 quarters. - FY2020-Q1RestatedAnnual report
「The Group's R&D activities amounted to ¥628 million during the first quarter. There were no material changes in the status of the Group's R&D activities during the first quarter.」
The Company stated that there were no material changes in its R&D activities and reported R&D expenses of ¥628 million for the first quarter. - FY2019AdvancedAnnual report
「The Company has strengthened its collaboration and cooperation with the Toshiba Group and business partners, and is efficiently advancing the research and development and commercialization of advanced technologies. Group-wide R&D expenses for the fiscal year were ¥2,742 million.」
The description of its collaboration partners expanded to include the Toshiba Group and business partners, and R&D expenses reached ¥2,742 million. Specific development initiatives including FPDs, semiconductors, OLEDs and microLEDs were also described. - FY2019-Q3RestatedAnnual report
「The Group's R&D activities amounted to ¥2,086 million during the first 3 quarters. There were no material changes in the status of the Group's R&D activities during the first 3 quarters.」
The Company stated that there were no material changes in its R&D activities and reported R&D expenses of ¥2,086 million for the first 3 quarters. - FY2019-Q2RestatedAnnual report
「The Group's R&D activities amounted to ¥1,403 million during the first 2 quarters. There were no material changes in the status of the Group's R&D activities during the first 2 quarters.」
The Company stated that there were no material changes in its R&D activities and reported R&D expenses of ¥1,403 million for the first 2 quarters. - FY2019-Q1RestatedAnnual report
「The Group's R&D activities amounted to ¥686 million during the first quarter. There were no material changes in the status of the Group's R&D activities during the first quarter.」
There were no material changes in the R&D activities, and R&D expenses for the quarter were ¥686 million. - FY2018RestatedAnnual report
「The Company has strengthened its collaboration and cooperation with Toshiba Corporation's Research and Development Center and Production Engineering Center, and is efficiently advancing the research and development and commercialization of advanced technologies. Group-wide R&D expenses for the fiscal year were ¥2,492 million.」
The Company continued the research and commercialization of advanced technologies through collaboration with Toshiba, with R&D expenses of ¥2,492 million. - FY2018-Q3RestatedAnnual report
「The Group's R&D activities amounted to ¥1,770 million during the first 3 quarters. There were no material changes in the status of the Group's R&D activities during the first 3 quarters.」
The Company continued its R&D activities, bringing cumulative R&D expenses to ¥1,770 million, but stated that there were no material changes in the status of its activities. - FY2018-Q2RestatedAnnual report
「The Group's R&D activities amounted to ¥1,234 million during the first 2 quarters. There were no material changes in the status of the Group's R&D activities during the first 2 quarters.」
The Company continued its R&D activities, with cumulative R&D expenses of ¥1,234 million. It stated that there were no material changes in the status of its activities. - FY2018-Q1RestatedAnnual report
「The Group's R&D activities amounted to ¥556 million during the first quarter. There were no material changes in the status of the Group's R&D activities during the first quarter.」
The Company stated that it continued its R&D activities and that there were no material changes during the quarter. R&D expenses were ¥556 million. - FY2017-Q3RestatedAnnual report
「The Group's R&D activities amounted to ¥1,599 million during the first 3 quarters. There were no material changes in the status of the Group's R&D activities during the first 3 quarters.」
The Company explicitly stated that it continued its R&D activities with no material changes during the quarter. Cumulative R&D expenses were ¥1,599 million. - FY2017-Q2RestatedAnnual report
「The Group's R&D activities amounted to ¥1,066 million during the first 2 quarters. There were no material changes in the status of the Group's R&D activities during the first 2 quarters.」
The Company stated that it continued its R&D activities and that there were no material changes during the quarter. No specific changes in collaboration or commercialization with Toshiba were described. - FY2016First statedAnnual report
「The Company has strengthened its collaboration and cooperation with Toshiba Corporation's Research and Development Center, Production Engineering Center and Storage & Device Solutions Company, and is efficiently advancing the research and development and commercialization of advanced technologies. Group-wide R&D expenses for the fiscal year were ¥2,064 million.」
With approximately 290 R&D staff and R&D expenses of ¥2,064 million, the Company is strengthening collaboration with Toshiba and advancing commercialization.